Kensington Investment Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Littelfuse
LFUS
|
+$1.2M |
| 2 |
Markel Group
MKL
|
+$561K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$458K |
| 4 |
Clorox
CLX
|
+$429K |
| 5 |
Amazon
AMZN
|
+$337K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$2.17M |
| 2 |
Jack Henry & Associates
JKHY
|
+$1.28M |
| 3 |
Bio-Techne
TECH
|
+$1.02M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$924K |
| 5 |
West Pharmaceutical
WST
|
+$895K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.32% |
| 2 | Financials | 17.6% |
| 3 | Healthcare | 17.22% |
| 4 | Industrials | 10.53% |
| 5 | Consumer Staples | 9.49% |
Similar funds
Kensington Investment Counsel's Q1 2022 Portfolio in Review
As of Q1 2022, Kensington Investment Counsel held 91 positions worth $151M, down 12% from $172M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Kensington Investment Counsel withdrew a net $5.22M in Q1 2022, closing 4 positions and reducing 35 holdings. Its most notable exit was Tandem Diabetes Care, an estimated $2.17M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Kensington Investment Counsel opened a new position in Littelfuse worth $1.13M.
- Kensington Investment Counsel's largest Q1 2022 buy was Littelfuse: 4,529 shares worth $1.13M.
- Kensington Investment Counsel added most to Markel Group in Q1 2022, an estimated $561K increase.
- Kensington Investment Counsel's biggest Q1 2022 reduction was Bio-Techne, cutting an estimated $1.02M.
- Kensington Investment Counsel fully exited Tandem Diabetes Care in Q1 2022, selling an estimated $2.17M.
- Kensington Investment Counsel's ten largest holdings make up 26% of its $151M portfolio in Q1 2022.
- Kensington Investment Counsel opened 3 new positions and closed 4 in Q1 2022.
- Kensington Investment Counsel's portfolio value fell 12% quarter-over-quarter to $151M.
Based on Kensington Investment Counsel's 13F filing for Q1 2022, filed 13 May 2022.